The latest report published by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on cardiac biomarkers market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global cardiac biomarkers market size reached US$ 10.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032.

Cardiac biomarkers are biological molecules found in blood, other body fluids, or tissues that are released in response to cardiac stress or damage, playing a crucial role in diagnosing various heart-related conditions. These biomarkers are pivotal for the early detection and management of heart diseases, including myocardial infarction, congestive heart failure, and acute coronary syndrome. They possess unique characteristics such as specificity to cardiac tissue and a correlation with heart disease severity, making them indispensable tools in clinical cardiology. Their working mechanism involves elevating in concentration in the bloodstream following cardiac injury, thereby enabling healthcare professionals to promptly diagnose and assess the extent of heart damage.

Request to Get the Sample Report: https://www.imarcgroup.com/cardiac-biomarkers-market/requestsample

Market Trends:

The global market is primarily driven by the rising prevalence of cardiovascular diseases. This trend is coupled with the growing awareness about the importance of early detection and management of heart conditions. Moreover, the advancement in biomarker research is significantly contributing to the development of more sensitive and specific biomarkers, enhancing diagnostic accuracy. The increasing adoption of point-of-care testing for cardiac biomarkers in emergency settings is also propelling the market forward. Besides this, the growing geriatric population, more prone to cardiac ailments, is providing a boost to the demand for these diagnostic tools. Additionally, the rising healthcare expenditure and improved healthcare infrastructure in various regions are facilitating wider access to advanced cardiac biomarker testing. The market is further driven by the integration of AI and machine learning in diagnostic procedures, improving the predictive analysis of heart diseases.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/cardiac-biomarkers-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • Alere Inc.
  • Beckman Coulter
  • Becton
  • Dickinson And Co.
  • Biomerieux
  • Bio-Rad Laboratories
  • Randox Laboratories
  • Roche Diagnostics Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific

Cardiac Biomarkers Market Segmentation:

Our report has categorized the market based on region, type, location of testing, and application.

Breakup by Type:

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others

Breakup by Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Regional Insights:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163